BAROPHARM Co., Ltd. (KOSDAQ:0153R0)
6,700.00
-610.00 (-8.34%)
At close: Nov 17, 2026
BAROPHARM Revenue
BAROPHARM had revenue of 49.55B KRW in the quarter ending September 30, 2026, with 144.57% growth. This brings the company's total for the last twelve months to 145.03B. In the year 2025, BAROPHARM had annual revenue of 96.72B with 112.40% growth. That makes BAROPHARM the 22,073rd largest company in the world by revenue and 1,219th in South Korea.
Revenue (ttm)
145.03B
Revenue Growth
+112.40%
P/S Ratio
0.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
80.17B
Revenue by Segment
- Sales of Health Functional Foods, Etc. 84.10B 82.9%
- Platform Service 17.39B 17.1%
Fiscal year ended Dec 31, 2025 See the full BAROPHARM breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 96.72B | 51.19B | 112.40% |
| Dec 31, 2024 | 45.54B | 33.95B | 292.88% |
| Dec 31, 2023 | 11.59B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.